Vaccines, Virus-Like Particle
"Vaccines, Virus-Like Particle" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines using supra-molecular structures composed of multiple copies of recombinantly expressed viral structural proteins. They are often antigentically indistinguishable from the virus from which they were derived.
| Descriptor ID |
D058425
|
| MeSH Number(s) |
D12.776.828.868.955 D20.215.894.865.955 D23.050.865.955
|
| Concept/Terms |
Vaccines, Virus-Like Particle- Vaccines, Virus-Like Particle
- Particle Vaccines, Virus-Like
- Vaccines, Virus Like Particle
- Virus-Like Particle Vaccines
- Virus Like Particle Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Virus-Like Particle".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Virus-Like Particle".
This graph shows the total number of publications written about "Vaccines, Virus-Like Particle" by people in this website by year, and whether "Vaccines, Virus-Like Particle" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 3 | 1 | 4 |
| 2017 | 19 | 5 | 24 |
| 2018 | 11 | 1 | 12 |
| 2019 | 7 | 2 | 9 |
| 2020 | 2 | 2 | 4 |
| 2021 | 2 | 4 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Vaccines, Virus-Like Particle" by people in Profiles.
-
An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity. Vaccine. 2021 08 16; 39(35):4988-5001.
-
Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity. EMBO Rep. 2021 08 04; 22(8):e52447.
-
Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization. Commun Biol. 2021 05 19; 4(1):597.
-
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat Med. 2021 06; 27(6):1071-1078.
-
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages. Int Immunopharmacol. 2021 Jul; 96:107763.
-
Characterization of HIV-1 virus-like particles and determination of Gag stoichiometry for different production platforms. Biotechnol Bioeng. 2021 07; 118(7):2660-2675.
-
Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization. PLoS Pathog. 2021 04; 17(4):e1009064.
-
Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses. Virology. 2021 07; 559:165-172.
-
Innovators target vaccines for variants and shortages in global South. Nat Biotechnol. 2021 04; 39(4):393-396.
-
COVID-19 vaccine decisions: considering the choices and opportunities. Microbes Infect. 2021 May-Jun; 23(4-5):104811.